Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | SI | P14410 | 4/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18364666 | 0.85 | HTR2A (0.48) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL21202506 | 0.82 | MGAM (0.41) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL18364658 | 0.81 | MAPT (0.46) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL6379817 | 0.81 | MAPT (0.56) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL13763231 | 0.77 | MAPT (0.59) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL8213938 | 0.77 | MAPT (0.67) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL18374989 | 0.76 | CDK4 (0.52) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL29871427 | 0.75 | MAPT (0.57) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL13763230 | 0.75 | MGAM (0.58) | MAPTGPR84FFAR1MEN1KMT2A | |
| SCHEMBL28767073 | 0.75 | MAPT (0.54) | MAPTGPR84FFAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | MSMO1, NOM1, CD68 | MAPT 293/4885GPR84 2980/4885FFAR1 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.